Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Improving vaccination rates in older adults and at-risk groups: focus on pertussis.

Aging clinical and experimental research

Choi JH, Correia de Sousa J, Fletcher M, Gabutti G, Harrington L, Holden M, Kim H, Michel JP, Mukherjee P, Nolan T, Welte T, Maggi S.
PMID: 35001333
Aging Clin Exp Res. 2022 Jan 10; doi: 10.1007/s40520-021-02018-3. Epub 2022 Jan 10.

Despite the implementation of effective paediatric vaccination programmes, pertussis remains a global health problem. Disease epidemiology has changed over time, shifting towards the adolescent and adult populations. In adults, the true burden of pertussis is greatly underestimated and pertussis...

Cite
Choi JH, Correia de Sousa J, Fletcher M, et al. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022;doi: 10.1007/s40520-021-02018-3.
Choi, J. H., Correia de Sousa, J., Fletcher, M., Gabutti, G., Harrington, L., Holden, M., Kim, H., Michel, J. P., Mukherjee, P., Nolan, T., Welte, T., & Maggi, S. (2022). Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging clinical and experimental research, . https://doi.org/10.1007/s40520-021-02018-3
Choi, Jung-Hyun, et al. "Improving vaccination rates in older adults and at-risk groups: focus on pertussis." Aging clinical and experimental research vol. (2022). doi: https://doi.org/10.1007/s40520-021-02018-3
Choi JH, Correia de Sousa J, Fletcher M, Gabutti G, Harrington L, Holden M, Kim H, Michel JP, Mukherjee P, Nolan T, Welte T, Maggi S. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022 Jan 10; doi: 10.1007/s40520-021-02018-3. Epub 2022 Jan 10. PMID: 35001333.
Copy Download .nbib Format: NLM
Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document.

The Journal of asthma : official journal of the Association for the Care of Asthma

Braido F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, Cosini F, Correia de Sousa J, Bikov A, Novakova S, Labor M, Kaidashev I, Nedeva D, Kowal K, Mihaicuta S, Urrutia Pereira M, Solé D, Novakova P, Chong-Neto H, Vrzy L, Ansotegui IJ, Bernstein JA, Boulet LP, Canonica GW, Dubuske L, Nunes C, Ivancevich JC, Santus P, Rosario N, Emelyanov A, Steiropoulos P.
PMID: 34936532
J Asthma. 2021 Dec 22;1-16. doi: 10.1080/02770903.2021.2022160. Epub 2021 Dec 22.

The optimal use of drug combinations for the management of asthma is providing significant results. This has prompted INTERASMA (Global Asthma Association) to take a position on inhaled triple therapy in asthma. Starting from an extensive literature review, Interasma...

Cite
Braido F, Tiotiu A, Guidos-Fogelbach G, et al. Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. J Asthma. 2021;1-16doi: 10.1080/02770903.2021.2022160.
Braido, F., Tiotiu, A., Guidos-Fogelbach, G., Baiardini, I., Cosini, F., Correia de Sousa, J., Bikov, A., Novakova, S., Labor, M., Kaidashev, I., Nedeva, D., Kowal, K., Mihaicuta, S., Urrutia Pereira, M., Solé, D., Novakova, P., Chong-Neto, H., Vrzy, L., Ansotegui, I. J., Bernstein, J. A., Boulet, L. P., Canonica, G. W., Dubuske, L., Nunes, C., Ivancevich, J. C., Santus, P., Rosario, N., Emelyanov, A., & Steiropoulos, P. (2021). Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. The Journal of asthma : official journal of the Association for the Care of Asthma, 1-16. https://doi.org/10.1080/02770903.2021.2022160
Braido, Fulvio, et al. "Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document." The Journal of asthma : official journal of the Association for the Care of Asthma vol. (2021): 1-16. doi: https://doi.org/10.1080/02770903.2021.2022160
Braido F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, Cosini F, Correia de Sousa J, Bikov A, Novakova S, Labor M, Kaidashev I, Nedeva D, Kowal K, Mihaicuta S, Urrutia Pereira M, Solé D, Novakova P, Chong-Neto H, Vrzy L, Ansotegui IJ, Bernstein JA, Boulet LP, Canonica GW, Dubuske L, Nunes C, Ivancevich JC, Santus P, Rosario N, Emelyanov A, Steiropoulos P. Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. J Asthma. 2021 Dec 22;1-16. doi: 10.1080/02770903.2021.2022160. Epub 2021 Dec 22. PMID: 34936532.
Copy Download .nbib Format: NLM
Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy.

Cellular and molecular gastroenterology and hepatology

Dolicka D, Sobolewski C, Gjorgjieva M, Correia de Sousa M, Berthou F, De Vito C, Colin DJ, Bejuy O, Fournier M, Maeder C, Blackshear PJ, Rubbia-Brandt L, Foti M.
PMID: 32987153
Cell Mol Gastroenterol Hepatol. 2021;11(2):597-621. doi: 10.1016/j.jcmgh.2020.09.012. Epub 2020 Sep 25.

BACKGROUND & AIMS: Tristetraprolin (TTP) is a key post-transcriptional regulator of inflammatory and oncogenic transcripts. Accordingly, TTP was reported to act as a tumor suppressor in specific cancers. Herein, we investigated how TTP contributes to the development of liver...

Cite
Dolicka D, Sobolewski C, Gjorgjieva M, et al. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. Cell Mol Gastroenterol Hepatol. 2020;11(2):597-621doi: 10.1016/j.jcmgh.2020.09.012.
Dolicka, D., Sobolewski, C., Gjorgjieva, M., Correia de Sousa, M., Berthou, F., De Vito, C., Colin, D. J., Bejuy, O., Fournier, M., Maeder, C., Blackshear, P. J., Rubbia-Brandt, L., & Foti, M. (2021). Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. Cellular and molecular gastroenterology and hepatology, 11(2), 597-621. https://doi.org/10.1016/j.jcmgh.2020.09.012
Dolicka, Dobrochna, et al. "Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy." Cellular and molecular gastroenterology and hepatology vol. 11,2 (2021): 597-621. doi: https://doi.org/10.1016/j.jcmgh.2020.09.012
Dolicka D, Sobolewski C, Gjorgjieva M, Correia de Sousa M, Berthou F, De Vito C, Colin DJ, Bejuy O, Fournier M, Maeder C, Blackshear PJ, Rubbia-Brandt L, Foti M. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. Cell Mol Gastroenterol Hepatol. 2021;11(2):597-621. doi: 10.1016/j.jcmgh.2020.09.012. Epub 2020 Sep 25. PMID: 32987153; PMCID: PMC7806869.
Copy Download .nbib Format: NLM
Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review.

Chest

Tabyshova A, Hurst JR, Soriano JB, Checkley W, Wan-Chun Huang E, Trofor AC, Flores-Flores O, Alupo P, Gianella G, Ferdous T, Meharg D, Alison J, Correia de Sousa J, Postma MJ, Chavannes NH, van Boven JFM.
PMID: 33038390
Chest. 2021 Feb;159(2):575-584. doi: 10.1016/j.chest.2020.09.260. Epub 2020 Oct 08.

BACKGROUND: Guidelines are critical for facilitating cost-effective COPD care. Development and implementation in low-and middle-income countries (LMICs) is challenging. To guide future strategy, an overview of current global COPD guidelines is required.RESEARCH QUESTION: We systematically reviewed national COPD guidelines,...

Cite
Tabyshova A, Hurst JR, Soriano JB, et al. Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review. Chest. 2020;159(2):575-584doi: 10.1016/j.chest.2020.09.260.
Tabyshova, A., Hurst, J. R., Soriano, J. B., Checkley, W., Wan-Chun Huang, E., Trofor, A. C., Flores-Flores, O., Alupo, P., Gianella, G., Ferdous, T., Meharg, D., Alison, J., Correia de Sousa, J., Postma, M. J., Chavannes, N. H., & van Boven, J. F. M. (2021). Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review. Chest, 159(2), 575-584. https://doi.org/10.1016/j.chest.2020.09.260
Tabyshova, Aizhamal, et al. "Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review." Chest vol. 159,2 (2021): 575-584. doi: https://doi.org/10.1016/j.chest.2020.09.260
Tabyshova A, Hurst JR, Soriano JB, Checkley W, Wan-Chun Huang E, Trofor AC, Flores-Flores O, Alupo P, Gianella G, Ferdous T, Meharg D, Alison J, Correia de Sousa J, Postma MJ, Chavannes NH, van Boven JFM. Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review. Chest. 2021 Feb;159(2):575-584. doi: 10.1016/j.chest.2020.09.260. Epub 2020 Oct 08. PMID: 33038390; PMCID: PMC7856534.
Copy Download .nbib Format: NLM
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor.

GE Portuguese journal of gastroenterology

Rocha M, Correia de Sousa J, Salgado M, Araújo A, Pedroto I.
PMID: 31328141
GE Port J Gastroenterol. 2019 Jul;26(4):268-274. doi: 10.1159/000494569. Epub 2018 Dec 17.

Immune checkpoint inhibitors have shown anti-tumour activity in cancers such as melanoma, renal cell carcinoma, non-small-cell lung cancer, urothelial carcinoma, colorectal cancer, and Hodgkin's lymphoma. Though immune checkpoint inhibitors have revolutionized the treatment and prognosis of some advanced malignancies,...

Cite
Rocha M, Correia de Sousa J, Salgado M, et al. Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor. GE Port J Gastroenterol. 2018;26(4):268-274doi: 10.1159/000494569.
Rocha, M., Correia de Sousa, J., Salgado, M., Araújo, A., & Pedroto, I. (2019). Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor. GE Portuguese journal of gastroenterology, 26(4), 268-274. https://doi.org/10.1159/000494569
Rocha, Marta, et al. "Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor." GE Portuguese journal of gastroenterology vol. 26,4 (2019): 268-274. doi: https://doi.org/10.1159/000494569
Rocha M, Correia de Sousa J, Salgado M, Araújo A, Pedroto I. Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor. GE Port J Gastroenterol. 2019 Jul;26(4):268-274. doi: 10.1159/000494569. Epub 2018 Dec 17. PMID: 31328141; PMCID: PMC6624661.
Copy Download .nbib Format: NLM
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis.

Cancers

Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clément S, Maeder C, Dolicka D, Fournier M, Vinet L, Montet X, Dufour JF, Humar B, Negro F, Sempoux C, Foti M.
PMID: 34638467
Cancers (Basel). 2021 Oct 04;13(19). doi: 10.3390/cancers13194983.

The microRNA 21 (miR-21) is upregulated in almost all known human cancers and is considered a highly potent oncogene and potential therapeutic target for cancer treatment. In the liver, miR-21 was reported to promote hepatic steatosis and inflammation, but...

Cite
Correia de Sousa M, Calo N, Sobolewski C, et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194983.
Correia de Sousa, M., Calo, N., Sobolewski, C., Gjorgjieva, M., Clément, S., Maeder, C., Dolicka, D., Fournier, M., Vinet, L., Montet, X., Dufour, J. F., Humar, B., Negro, F., Sempoux, C., & Foti, M. (2021). Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers, 13(19), . https://doi.org/10.3390/cancers13194983
Correia de Sousa, Marta, et al. "Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194983
Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clément S, Maeder C, Dolicka D, Fournier M, Vinet L, Montet X, Dufour JF, Humar B, Negro F, Sempoux C, Foti M. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021 Oct 04;13(19). doi: 10.3390/cancers13194983. PMID: 34638467; PMCID: PMC8508272.
Copy Download .nbib Format: NLM
COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?.

Pulmonology

Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J.
PMID: 32169297
Pulmonology. 2020 Mar 10; doi: 10.1016/j.pulmoe.2020.02.003. Epub 2020 Mar 10.

OBJECTIVES: To evaluate the degree to which evidence from large clinical trials can be applied to patients treated in a local hospital cohort of COPD outpatients.METHODS: The authors selected seventeen RCTs identified in a systematic way from GOLD 2019...

Cite
Duarte-de-Araújo A, Teixeira P, Hespanhol V, et al. COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?. Pulmonology. 2020;doi: 10.1016/j.pulmoe.2020.02.003.
Duarte-de-Araújo, A., Teixeira, P., Hespanhol, V., & Correia-de-Sousa, J. (2020). COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?. Pulmonology, . https://doi.org/10.1016/j.pulmoe.2020.02.003
Duarte-de-Araújo, António, et al. "COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?." Pulmonology vol. (2020). doi: https://doi.org/10.1016/j.pulmoe.2020.02.003
Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?. Pulmonology. 2020 Mar 10; doi: 10.1016/j.pulmoe.2020.02.003. Epub 2020 Mar 10. PMID: 32169297.
Copy Download .nbib Format: NLM
Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document.

The Journal of asthma : official journal of the Association for the Care of Asthma

Braido F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, Cosini F, Correia de Sousa J, Bikov A, Novakova S, Labor M, Kaidashev I, Nedeva D, Kowal K, Mihaicuta S, Urrutia Pereira M, Solé D, Novakova P, Chong-Neto H, Vrzy L, Ansotegui IJ, Bernstein JA, Boulet LP, Canonica GW, Dubuske L, Nunes C, Ivancevich JC, Santus P, Rosario N, Emelyanov A, Steiropoulos P.
PMID: 34936532
J Asthma. 2022 Jan 11;1-11. doi: 10.1080/02770903.2021.2022160. Epub 2022 Jan 11.

No abstract available.

Cite
Braido F, Tiotiu A, Guidos-Fogelbach G, et al. Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. J Asthma. 2022;1-11doi: 10.1080/02770903.2021.2022160.
Braido, F., Tiotiu, A., Guidos-Fogelbach, G., Baiardini, I., Cosini, F., Correia de Sousa, J., Bikov, A., Novakova, S., Labor, M., Kaidashev, I., Nedeva, D., Kowal, K., Mihaicuta, S., Urrutia Pereira, M., Solé, D., Novakova, P., Chong-Neto, H., Vrzy, L., Ansotegui, I. J., Bernstein, J. A., Boulet, L. P., Canonica, G. W., Dubuske, L., Nunes, C., Ivancevich, J. C., Santus, P., Rosario, N., Emelyanov, A., & Steiropoulos, P. (2022). Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. The Journal of asthma : official journal of the Association for the Care of Asthma, 1-11. https://doi.org/10.1080/02770903.2021.2022160
Braido, Fulvio, et al. "Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document." The Journal of asthma : official journal of the Association for the Care of Asthma vol. (2022): 1-11. doi: https://doi.org/10.1080/02770903.2021.2022160
Braido F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, Cosini F, Correia de Sousa J, Bikov A, Novakova S, Labor M, Kaidashev I, Nedeva D, Kowal K, Mihaicuta S, Urrutia Pereira M, Solé D, Novakova P, Chong-Neto H, Vrzy L, Ansotegui IJ, Bernstein JA, Boulet LP, Canonica GW, Dubuske L, Nunes C, Ivancevich JC, Santus P, Rosario N, Emelyanov A, Steiropoulos P. Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document. J Asthma. 2022 Jan 11;1-11. doi: 10.1080/02770903.2021.2022160. Epub 2022 Jan 11. PMID: 34936532.
Copy Download .nbib Format: NLM
Improving vaccination rates in older adults and at-risk groups: focus on pertussis.

Aging clinical and experimental research

Choi JH, Correia de Sousa J, Fletcher M, Gabutti G, Harrington L, Holden M, Kim H, Michel JP, Mukherjee P, Nolan T, Welte T, Maggi S.
PMID: 35001333
Aging Clin Exp Res. 2022 Jan 10; doi: 10.1007/s40520-021-02018-3. Epub 2022 Jan 10.

Despite the implementation of effective paediatric vaccination programmes, pertussis remains a global health problem. Disease epidemiology has changed over time, shifting towards the adolescent and adult populations. In adults, the true burden of pertussis is greatly underestimated and pertussis...

Cite
Choi JH, Correia de Sousa J, Fletcher M, et al. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022;doi: 10.1007/s40520-021-02018-3.
Choi, J. H., Correia de Sousa, J., Fletcher, M., Gabutti, G., Harrington, L., Holden, M., Kim, H., Michel, J. P., Mukherjee, P., Nolan, T., Welte, T., & Maggi, S. (2022). Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging clinical and experimental research, . https://doi.org/10.1007/s40520-021-02018-3
Choi, Jung-Hyun, et al. "Improving vaccination rates in older adults and at-risk groups: focus on pertussis." Aging clinical and experimental research vol. (2022). doi: https://doi.org/10.1007/s40520-021-02018-3
Choi JH, Correia de Sousa J, Fletcher M, Gabutti G, Harrington L, Holden M, Kim H, Michel JP, Mukherjee P, Nolan T, Welte T, Maggi S. Improving vaccination rates in older adults and at-risk groups: focus on pertussis. Aging Clin Exp Res. 2022 Jan 10; doi: 10.1007/s40520-021-02018-3. Epub 2022 Jan 10. PMID: 35001333; PMCID: PMC8743159.
Copy Download .nbib Format: NLM
Managing asthma in primary healthcare.

Minerva medica

Correia-DE-Sousa J, Vicente C, Brito D, Tsiligianni I, Kocks JW, Román-Rodriguez M, Baxter N, Maricoto T, Williams S.
PMID: 34814633
Minerva Med. 2021 Oct;112(5):582-604. doi: 10.23736/S0026-4806.21.07277-3.

Asthma brings considerable challenges for family doctors because of its variety of shapes, different levels of severity, a wide age range, and the fact that in the last decades clinicians are able to offer much better treatment options with...

Cite
Correia-DE-Sousa J, Vicente C, Brito D, et al. Managing asthma in primary healthcare. Minerva Med. 2021;112(5):582-604doi: 10.23736/S0026-4806.21.07277-3.
Correia-DE-Sousa, J., Vicente, C., Brito, D., Tsiligianni, I., Kocks, J. W., Román-Rodriguez, M., Baxter, N., Maricoto, T., & Williams, S. (2021). Managing asthma in primary healthcare. Minerva medica, 112(5), 582-604. https://doi.org/10.23736/S0026-4806.21.07277-3
Correia-DE-Sousa, Jaime, et al. "Managing asthma in primary healthcare." Minerva medica vol. 112,5 (2021): 582-604. doi: https://doi.org/10.23736/S0026-4806.21.07277-3
Correia-DE-Sousa J, Vicente C, Brito D, Tsiligianni I, Kocks JW, Román-Rodriguez M, Baxter N, Maricoto T, Williams S. Managing asthma in primary healthcare. Minerva Med. 2021 Oct;112(5):582-604. doi: 10.23736/S0026-4806.21.07277-3. PMID: 34814633.
Copy Download .nbib Format: NLM
Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG.

NPJ primary care respiratory medicine

Cragg L, Williams S, van der Molen T, Thomas M, Correia de Sousa J, Chavannes NH.
PMID: 27654071
NPJ Prim Care Respir Med. 2016 Sep 22;26:16048. doi: 10.1038/npjpcrm.2016.48.

No abstract available.

Cite
Cragg L, Williams S, van der Molen T, et al. Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016;26:16048doi: 10.1038/npjpcrm.2016.48.
Cragg, L., Williams, S., van der Molen, T., Thomas, M., Correia de Sousa, J., & Chavannes, N. H. (2016). Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG. NPJ primary care respiratory medicine, 2616048. https://doi.org/10.1038/npjpcrm.2016.48
Cragg, Liza, et al. "Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG." NPJ primary care respiratory medicine vol. 26 (2016): 16048. doi: https://doi.org/10.1038/npjpcrm.2016.48
Cragg L, Williams S, van der Molen T, Thomas M, Correia de Sousa J, Chavannes NH. Fostering the exchange of real-life data across different countries to answer primary care research questions: a protocol for an UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016 Sep 22;26:16048. doi: 10.1038/npjpcrm.2016.48. PMID: 27654071; PMCID: PMC5113010.
Copy Download .nbib Format: NLM
Routine primary care data-the new crystal ball?.

Journal of thoracic disease

Correia de Sousa J.
PMID: 27500003
J Thorac Dis. 2016 Jul;8:S447. doi: 10.21037/jtd.2016.06.69.

No abstract available.

Cite
Correia de Sousa J. Routine primary care data-the new crystal ball?. J Thorac Dis. 2016;8:S447doi: 10.21037/jtd.2016.06.69.
Correia de Sousa, J. (2016). Routine primary care data-the new crystal ball?. Journal of thoracic disease, 8S447. https://doi.org/10.21037/jtd.2016.06.69
Correia de Sousa, Jaime. "Routine primary care data-the new crystal ball?." Journal of thoracic disease vol. 8 (2016): S447. doi: https://doi.org/10.21037/jtd.2016.06.69
Correia de Sousa J. Routine primary care data-the new crystal ball?. J Thorac Dis. 2016 Jul;8:S447. doi: 10.21037/jtd.2016.06.69. PMID: 27500003; PMCID: PMC4958771.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries